Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by elgin1on May 28, 2020 9:44pm
95 Views
Post# 31085666

RE:RE:House Positions; nothing wrong

RE:RE:House Positions; nothing wrong
BioTeck wrote: Bravo, great post close wrapup Wally! Very enlightening and informative. I'm sure sonny ol' boy will appreciate it. Scroll down to page 23 of 28 of diabetes Canada no limits presentation. Dollars to doughnuts that Wally's expected news will be regarding immunosuppression. "Immune suppression technology not disclosed yet." Wally also kindly highlighted it the last news release. Sounds like selfie has promised some news based on jwall and sonny and the amount of selling occuring. Will be another news release "aimed towards pharma not investors". How many times have you heard that one before? Is it their old Sertoli tech that didn't work or are they buying or leasing some other technology is the question. Putting the cart infront of the horse if you ask me. Hope the have the money if it's the latter. Anyone know how many of the 7 patients they have enrolled? The study is ending in a couple months and only 90 day data has been released on ONE patient and focus seems to be shifting to hemophilia. Will a PP be announced? Tune in tomorrow to find out! Scary stuff!



” Dollars to donughnuts “ news will be about immunosuppresion .... wow Bioteck it would be a real coincidence it that were true . Let’s see what happens .  Also the pharma collaboration is not disclosed yet . But if news is about immunosuppresion like you say I think it is more than a lucky guess on your part..... 

 “Stating they are buying or leasing other technology “ where did you get that from Bioteck ? Let me guess another lucky guess.  Wow Bioteck with all these dollar to doughnut assumptions, it seems like you still work there ?

You should worry more about Viacycte than Sva .... oh yeah I remembered you own free shares that’s why you constantly bash it.

Bullboard Posts